PHARMING GROUP
Identification
Symbole
PHARM
Code ISIN
NL0000377018
Exchange / Market
Euronext
Trading location
Amsterdam
Famille de produits
Stocks
Market organization
Euronext-LocalSecurities
ICB
Biotechnology
Description de l'activité
Pharming Group specializes in the development of innovative products for the treatment of genetic disorders, specialty products for surgical indications, and nutritional products. The group's technologies include innovative platforms for the production of protein therapeutics, technology and processes for the purification and formulation of these products, as well as technology in the field of DNA repair (DNAge). Net sales break down by type of revenues into grants (69.4%) and licence fees (30.6%).
Site internet
www.pharming.com
Issuer website
www.pharming.com
Operation
Date de l'IPO
jeu 27/05/2010
Type d'IPO
Initial Public offering
New Issue Special Session
Catégorie
New Issue Special Session
Operation procedure
OFFER SHARES